GLP Ligand Binding Assay Bioanalysis

Peptides, monoclonal antibodies (mAb), multi-domain antibodies, antibody-drug conjugates (ADC), biosimilars, and traditional and next-generation oligonucleotides—Charles River scientists are global leaders in this rapidly growing and evolving field. Ligand binding assay bioanalysis is not an independent discipline, our scientists work closely with our immunogenicity, pharmacokinetic and statistical specialists to deliver the pertinent solutions and interpretations applicable to your molecule and your study.

Contact Our Team About Your Project

  • Ligand binding assays (ELISA and MSD)
  • Automated ELISA systems
  • Ligand binding with LC-MS detection (Hybrid hybrid assays)
  • LC-MS/MS
  • Oligonucleotides
  • High-resolution mass spectrometry
  • Luminex® technologies
  • Radioimmunoassay (RIA)
  • Enzyme immunoassay (EIA)
  • Fluorescence immunoassay (FIA)
  • Immunoradiometric assay (IRMA)
  • Dissociation-enhanced lanthanide fluorescence immunoassay (DELFIA)
  • Scintillation proximity assay (SPA)

You may also be interested in...

The Advantages of Microsampling

Read this blog post on the importance of microsampling in safety assessment and some benefits that you may not have considered.

Immunology Services

We perform assessments for the global registration of pharmaceutical and biotechnology compounds.

Webinar Replay

View our webinar “The Use of Microsampling to Improve the Relevance of Toxicity Study Data.”